Bora Pharmaceuticals global capacity and capabilities update

On-demand webinar

Explore Bora Pharmaceuticals’ global manufacturing capacity, recent investments, and expanded capabilities across its CDMO network. In this on-demand webinar, Bora provides an update on its manufacturing footprint across North America and Taiwan, available capacity for new programs and technology transfers, and continued investments in infrastructure, technology, and strategic partnerships.

The session highlights recent capacity and capability investments, including new oral solid dose manufacturing and packaging equipment at Maple Grove, Minnesota, an automated vial, syringe, and cartridge filling line in Baltimore, Maryland, and expanded biologics manufacturing capabilities in Rockville, Maryland. The webinar also covers Bora’s strategic alliance with Corealis Pharma for end-to-end oral solid dose development, its partnership with Insilico Medicine, and how flexible teams and cross-site resources help support new programs and technology transfers across the network.

What you’ll learn

• Bora’s global manufacturing footprint and capabilities across oral solid dose, sterile fill-finish, biologics, ophthalmics, liquids, and semi-solids
• Recent capacity and infrastructure investments across Bora’s manufacturing network
• Expanded oral solid dose manufacturing and packaging capabilities at Maple Grove
• Recent sterile fill-finish and biologics capability expansions in Baltimore and Rockville
• How Bora supports new programs and technology transfers through scalable capacity, cross-site resources, and collaborative project onboarding